Why is Dentsply Sirona stock plunging today?
Dentsply Sirona (XRAY) shares fell 13% in pre-market trading after Q3 2026 results missed estimates, with revenue at $836M (-7.5% YoY) and EPS at $0.29. The company lowered full-year guidance, and analysts cut price targets, citing segment weakness and a challenging growth outlook.
How this was made
The 30-second read
Why it matters
The earnings miss and lowered guidance are likely to keep the stock under pressure throughout the trading day.
Market read
The earnings surprise and guidance reduction are the primary drivers of the stock's 13% pre‑market decline.
What to watch
Potential cost‑saving initiatives and upcoming product launches may mitigate long‑term impact.
Background
Dentsply Sirona reported Q3 2026 results with revenue down 7.5% YoY and EPS below forecasts, prompting analyst target cuts.
Market effects
Dental equipment sector faces broader pressure as Dentsply Sirona's miss may prompt re‑rating of peers.
U.S. market sees modest drag; the Dow under pressure while the Nasdaq holds gains.
Limited to U.S. equities; no immediate global macro effect.
Counterpoint
If the market overreacts to the guidance cut, a short‑term bounce could occur on any positive news.
Key entities
- companyDentsply Sirona
Dental equipment manufacturer (ticker DENT) reporting Q3 2026 earnings.
- analystMizuho
Maintained Neutral rating, cut price target to $11.
- analystBaird
Maintained Neutral rating, cut price target to $9.
